Abstract
The epidemiology of cardiac complications related to HIV including cardiomyopathy, increased left ventricular mass, myocarditis, pericardial effusion, endocarditis, and malignancy are discussed. A large number of HIV-infected individuals will present with cardiac complications in the next decade as chronic viral infection, co-infections, drug therapy, and immunosuppression affect the heart. Understanding the nature and course of cardiac illness related to HIV infection will allow appropriate monitoring, early intervention and therapy, and will provide a baseline to evaluate the effects of new therapeutic regimens such as highly active antiretroviral therapy on the cardiovascular system.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 13-22 |
| Number of pages | 10 |
| Journal | Annals of the New York Academy of Sciences |
| Volume | 946 |
| State | Published - Jan 1 2001 |
Keywords
- Cardiomyopathy
- HIV infection
- Pericardial effusion
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
Fingerprint Dive into the research topics of 'Epidemiology of cardiovascular involvement in HIV disease and AIDS'. Together they form a unique fingerprint.
Cite this
Fisher, S. D., & Lipshultz, S. E. (2001). Epidemiology of cardiovascular involvement in HIV disease and AIDS. Annals of the New York Academy of Sciences, 946, 13-22.